HomeTVRD • NASDAQ
add
Tvardi Therapeutics Inc
Previous close
$26.52
Day range
$24.34 - $27.27
Year range
$8.13 - $34.31
Market cap
227.81M USD
Avg Volume
46.33K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.57M | 20.33% |
Operating expense | 4.64M | -31.98% |
Net income | -4.91M | 84.02% |
Net profit margin | -190.97 | 86.72% |
Earnings per share | -0.50 | 97.52% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.22M | -50.96% |
Total assets | 38.95M | -56.77% |
Total liabilities | 47.02M | -22.02% |
Total equity | -8.07M | — |
Shares outstanding | 9.36M | — |
Price to book | -5.00 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.91M | 84.02% |
Cash from operations | -4.69M | 84.59% |
Cash from investing | — | — |
Cash from financing | 1.01M | 246.86% |
Net change in cash | -3.69M | 28.94% |
Free cash flow | — | — |
About
Founded
2004
Headquarters
Website
Employees
10
